Report ID: SQMIG15E2437
Report ID:
SQMIG15E2437 |
Region:
Global |
Published Date: July, 2001
Pages:
247
|
Tables:
67 |
Figures:
75
In January 2022,The Leverkusen, a pharmaceutical company Bayer AG based in Germany announced the introduction of Ambition.An amino acid-based medication developed exclusively for the Chinese market. The substance includes glycine acid, glutamic, and alanine, and among its 19 various types of amino acids.
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATIONWant to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Report ID: SQMIG15E2437